These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12421550)

  • 41. Mathematical study of a staged-progression HIV model with imperfect vaccine.
    Gumel AB; McCluskey CC; van den Driessche P
    Bull Math Biol; 2006 Nov; 68(8):2105-28. PubMed ID: 16868850
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endemic threshold results in an age-duration-structured population model for HIV infection.
    Inaba H
    Math Biosci; 2006 May; 201(1-2):15-47. PubMed ID: 16466752
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modeling the virus-immune system interactions in the peripheral bloodstream of HIV infected individuals using a cellular automata model with considering the effects of antiretroviral therapy.
    Golpayegani GN; Jafari AH; Dabanloo NJ
    Technol Health Care; 2017; 25(1):59-88. PubMed ID: 27689554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction.
    Heeney J; Jonker R; Koornstra W; Dubbes R; Niphuis H; Di Rienzo AM; Gougeon ML; Montagnier L
    J Med Primatol; 1993; 22(2-3):194-200. PubMed ID: 8105093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased CD4+ T-lymphocyte senescence fraction in advanced human immunodeficiency virus type 1 infection.
    Nichols WS; Schneider S; Chan RC; Farthing CF; Daar ES
    Scand J Immunol; 1999 Mar; 49(3):302-6. PubMed ID: 10102648
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Faster progression to AIDS and AIDS-related death among seroincident individuals infected with recombinant HIV-1 A3/CRF02_AG compared with sub-subtype A3.
    Palm AA; Esbjörnsson J; Månsson F; Kvist A; Isberg PE; Biague A; da Silva ZJ; Jansson M; Norrgren H; Medstrand P
    J Infect Dis; 2014 Mar; 209(5):721-8. PubMed ID: 23935204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A stochastic model for early HIV-1 population dynamics.
    Tuckwell HC; Le Corfec E
    J Theor Biol; 1998 Dec; 195(4):451-63. PubMed ID: 9837702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bystander CD4+ T lymphocytes survive in HIV-infected human lymphoid tissue.
    Grivel JC; Biancotto A; Ito Y; Lima RG; Margolis LB
    AIDS Res Hum Retroviruses; 2003 Mar; 19(3):211-6. PubMed ID: 12689413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modeling deuterated glucose labeling of T-lymphocytes.
    Ribeiro RM; Mohri H; Ho DD; Perelson AS
    Bull Math Biol; 2002 Mar; 64(2):385-405. PubMed ID: 11926122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIV Controllers Exhibit Enhanced Frequencies of Major Histocompatibility Complex Class II Tetramer
    Laher F; Ranasinghe S; Porichis F; Mewalal N; Pretorius K; Ismail N; Buus S; Stryhn A; Carrington M; Walker BD; Ndung'u T; Ndhlovu ZM
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077659
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals.
    Zangerle R; Steinhuber S; Sarcletti M; Dierich MP; Wachter H; Fuchs D; Möst J
    Int Arch Allergy Immunol; 1998 Jul; 116(3):228-39. PubMed ID: 9693271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. α
    Cheung KW; Wu T; Ho SF; Wong YC; Liu L; Wang H; Chen Z
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29386290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamics of CD4+ T cells in HIV-1 infection.
    Ribeiro RM
    Immunol Cell Biol; 2007 Jun; 85(4):287-94. PubMed ID: 17389869
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduction of HIV concentration during acute infection: independence from a specific immune response.
    Phillips AN
    Science; 1996 Jan; 271(5248):497-9. PubMed ID: 8560262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of smoothing techniques for CD4 data in a Markov model with states defined by CD4: an example on the estimation of the HIV incubation time distribution.
    Sypsa V; Touloumi G; Kenward M; Karafoulidou A; Hatzakis A
    Stat Med; 2001 Dec; 20(24):3667-76. PubMed ID: 11782025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Programmed cell death in AIDS-related HIV and SIV infections.
    Gougeon ML; Garcia S; Heeney J; Tschopp R; Lecoeur H; Guetard D; Rame V; Dauguet C; Montagnier L
    AIDS Res Hum Retroviruses; 1993 Jun; 9(6):553-63. PubMed ID: 8102239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preferential apoptosis of HIV-1-specific CD4+ T cells.
    Yue FY; Kovacs CM; Dimayuga RC; Gu XX; Parks P; Kaul R; Ostrowski MA
    J Immunol; 2005 Feb; 174(4):2196-204. PubMed ID: 15699152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Levels of HIV-infected peripheral blood cells remain stable throughout the natural history of HIV-1 infection. Swiss HIV Cohort Study.
    Cone RW; Gowland P; Opravil M; Grob P; Ledergerber B
    AIDS; 1998 Dec; 12(17):2253-60. PubMed ID: 9863866
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Markov Chain Monte Carlo Approach to Estimate AIDS after HIV Infection.
    Apenteng OO; Ismail NA
    PLoS One; 2015; 10(7):e0131950. PubMed ID: 26147199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calculation and use of an HIV-1 disease progression score.
    Roussanov BV; Taylor JM; Giorgi JV
    AIDS; 2000 Dec; 14(17):2715-22. PubMed ID: 11125890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.